Position
Basepoint Wealth LLC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $88$775.33 → $777.06
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 51 | $39.5K | — | — | — | 0.0% |
| Q1 2026 | 51 | $39.6K | $777.06 | $88 | $0 | 0.0% |